Immunological effects of everolimus in patients with metastatic renal cell cancer

av Huijts, Charlotte M, Santegoets, Saskia J, de Jong, Tamarah D, Verheul, Henk M, de Gruijl, Tanja D, van der Vliet, Hans J
I publikationen Int J Immunopathol Pharmacol (2017)

Evaluation of a tyrosine kinase peptide microarray for tyrosine kinase inhibitor therapy selection in cancer

av Labots, Mariette, Gotink, Kristy J, Dekker, Henk, Azijli, Kaamar, van der Mijn, Johannes C, Huijts, Charlotte M, Piersma, Sander R, Jiménez, Connie R, Verheul, Henk M W
I publikationen Exp Mol Med (2016)

Phase I-II study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell cancer

av Huijts, Charlotte M, Santegoets, Saskia J, van den Eertwegh, Alfons J, Pijpers, Laura S, Haanen, John B, de Gruijl, Tanja D, Verheul, Henk M, van der Vliet, Hans J
Publicerad 2011

The effect of everolimus and low-dose cyclophosphamide on immune cell subsets in patients with metastatic renal cell carcinoma: results from a phase I clinical trial

av Huijts, Charlotte M., Lougheed, Sinéad M., Bodalal, Zuhir, van Herpen, Carla M., Hamberg, Paul, Tascilar, Metin, Haanen, John B., Verheul, Henk M., de Gruijl, Tanja D., van der Vliet, Hans J.
I publikationen Cancer Immunol Immunother (2019)

Phase 1 study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell carcinoma

av Huijts, Charlotte M., Werter, Inge M., Lougheed, Sinéad M., Goedegebuure, Ruben S., van Herpen, Carla M., Hamberg, Paul, Tascilar, Metin, Haanen, John B., Verheul, Henk M., de Gruijl, Tanja D., van der Vliet, Hans J.
I publikationen Cancer Immunol Immunother (2018)

Targeting Glutamine Metabolism in Breast Cancer with Aminooxyacetate

av Korangath, Preethi, Teo, Wei Wen, Sadik, Helen, Han, Liangfeng, Mori, Noriko, Huijts, Charlotte M., Wildes, Flonne, Bharti, Santosh, Zhang, Zhe, Santa-Maria, Cesar A., Tsai, Hualing, Dang, Chi V., Stearns, Vered, Bhujwalla, Zaver M., Sukumar, Saraswati
I publikationen Clin Cancer Res (2015)